Antibody Anti-SCGB2A1 used to explore the human lacrimal gland using organoids and single-cell sequencing
Article: "Exploring the human lacrimal gland using organoids and single-cell sequencing"
Treatment options for patients with lacrimal gland disorders are limited partly due to a lack of biological understanding.
Patient-derived organoids open up new avenues to study lacrimal gland biology and diseases.
Our secretoglobin antibody Anti-SCGB2A1 (HPA034584) is here used to explore the human lacrimal gland using organoids and single-cell sequencing
Find out more about our polyclonal antibody Anti-SCGB2A1 (HPA034584).